{"schema_version":"secwatch.filing_event.v1","accession":"0001370053-24-000003","form_type":"8-K","ticker":"ANAB","cik":"0001370053","company_name":"ANAPTYSBIO, INC","filed_at":"2024-01-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.971265+00:00","generated_at":"2026-06-07T03:01:05.308998+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"AnaptysBio expects $417M cash at year-end 2023; presents at JPM Healthcare Conference","bullets":["Preliminary cash, cash equivalents, and investments of approximately $417M as of December 31, 2023.","Presentation at J.P. Morgan Healthcare Conference on January 8, 2024; full corporate overview furnished as Exhibit 99.1.","Audited FY2023 financials not yet available; preliminary estimate subject to adjustment.","Presentation details (pipeline, clinical data) not fully available in the provided exhibit excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0001370053-24-000003","json":"https://secwatch.observer/filing/0001370053-24-000003.json","markdown":"https://secwatch.observer/filing/0001370053-24-000003.md","text":"https://secwatch.observer/filing/0001370053-24-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1370053/000137005324000003/0001370053-24-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1370053/000137005324000003/anab-20240105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T03:01:05.308998+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}